Cargando…

Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases

Anthocyanins are among the best-known phenolic compounds and possess remarkable biological activities, including antioxidant, anti-inflammatory, anticancer, and antidiabetic effects. Despite their therapeutic benefits, they are not widely used as health-promoting agents due to their instability, low...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Ana C., Falcão, Amílcar, Alves, Gilberto, Lopes, João A., Silva, Luís R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695229/
https://www.ncbi.nlm.nih.gov/pubmed/36365091
http://dx.doi.org/10.3390/pharmaceutics14112272
_version_ 1784838004122058752
author Gonçalves, Ana C.
Falcão, Amílcar
Alves, Gilberto
Lopes, João A.
Silva, Luís R.
author_facet Gonçalves, Ana C.
Falcão, Amílcar
Alves, Gilberto
Lopes, João A.
Silva, Luís R.
author_sort Gonçalves, Ana C.
collection PubMed
description Anthocyanins are among the best-known phenolic compounds and possess remarkable biological activities, including antioxidant, anti-inflammatory, anticancer, and antidiabetic effects. Despite their therapeutic benefits, they are not widely used as health-promoting agents due to their instability, low absorption, and, thus, low bioavailability and rapid metabolism in the human body. Recent research suggests that the application of nanotechnology could increase their solubility and/or bioavailability, and thus their biological potential. Therefore, in this review, we have provided, for the first time, a comprehensive overview of in vitro and in vivo studies on nanocarriers used as delivery systems of anthocyanins, and their aglycones, i.e., anthocyanidins alone or combined with conventional drugs in the treatment or management of chronic diseases.
format Online
Article
Text
id pubmed-9695229
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96952292022-11-26 Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases Gonçalves, Ana C. Falcão, Amílcar Alves, Gilberto Lopes, João A. Silva, Luís R. Pharmaceutics Review Anthocyanins are among the best-known phenolic compounds and possess remarkable biological activities, including antioxidant, anti-inflammatory, anticancer, and antidiabetic effects. Despite their therapeutic benefits, they are not widely used as health-promoting agents due to their instability, low absorption, and, thus, low bioavailability and rapid metabolism in the human body. Recent research suggests that the application of nanotechnology could increase their solubility and/or bioavailability, and thus their biological potential. Therefore, in this review, we have provided, for the first time, a comprehensive overview of in vitro and in vivo studies on nanocarriers used as delivery systems of anthocyanins, and their aglycones, i.e., anthocyanidins alone or combined with conventional drugs in the treatment or management of chronic diseases. MDPI 2022-10-24 /pmc/articles/PMC9695229/ /pubmed/36365091 http://dx.doi.org/10.3390/pharmaceutics14112272 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gonçalves, Ana C.
Falcão, Amílcar
Alves, Gilberto
Lopes, João A.
Silva, Luís R.
Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases
title Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases
title_full Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases
title_fullStr Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases
title_full_unstemmed Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases
title_short Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases
title_sort employ of anthocyanins in nanocarriers for nano delivery: in vitro and in vivo experimental approaches for chronic diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695229/
https://www.ncbi.nlm.nih.gov/pubmed/36365091
http://dx.doi.org/10.3390/pharmaceutics14112272
work_keys_str_mv AT goncalvesanac employofanthocyaninsinnanocarriersfornanodeliveryinvitroandinvivoexperimentalapproachesforchronicdiseases
AT falcaoamilcar employofanthocyaninsinnanocarriersfornanodeliveryinvitroandinvivoexperimentalapproachesforchronicdiseases
AT alvesgilberto employofanthocyaninsinnanocarriersfornanodeliveryinvitroandinvivoexperimentalapproachesforchronicdiseases
AT lopesjoaoa employofanthocyaninsinnanocarriersfornanodeliveryinvitroandinvivoexperimentalapproachesforchronicdiseases
AT silvaluisr employofanthocyaninsinnanocarriersfornanodeliveryinvitroandinvivoexperimentalapproachesforchronicdiseases